Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

✍ Scribed by Ott, P. A.; Hamid, O.; Pavlick, A. C.; Kluger, H.; Kim, K. B.; Boasberg, P. D.; Simantov, R.; Crowley, E.; Green, J. A.; Hawthorne, T.; Davis, T. A.; Sznol, M.; Hwu, P.

• Book ID: 126501677
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 254 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2013.54.8115